about
CIViC databaseThe selective MEK1 inhibitor Selumetinib enhances the antitumor activity of everolimus against renal cell carcinoma in vitro and in vivo.Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancerIdentification of HRAS as cancer-promoting gene in gastric carcinoma cell aggressiveness.Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations.Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Somatic mutations in salivary duct carcinoma and potential therapeutic targets.
P2860
Q27612411-C8D47E72-743E-46E5-858A-BA1BC9A4F9A6Q33591361-E7FA325A-8455-4718-A346-56C58357BF6CQ37203121-9D19DE91-3238-4016-A8F5-0EF46366BDA8Q37298284-1445343B-B941-4195-AA5F-972982009D1AQ38756560-5F33D593-1153-468A-A049-CA696A3D306FQ41280171-23B72105-AF75-45A8-9365-166CE94E2B82Q47110143-6F75A5AF-586D-4EF1-A87B-7A46E3E8CCD1Q47133482-9E85A085-5840-4897-92A5-3DC4C8A66044
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mutant HRAS as novel target for MEK and mTOR inhibitors
@ast
Mutant HRAS as novel target for MEK and mTOR inhibitors
@en
Mutant HRAS as novel target for MEK and mTOR inhibitors.
@nl
type
label
Mutant HRAS as novel target for MEK and mTOR inhibitors
@ast
Mutant HRAS as novel target for MEK and mTOR inhibitors
@en
Mutant HRAS as novel target for MEK and mTOR inhibitors.
@nl
altLabel
Mutant HRAS as novel target for MEK and mTOR inhibitors
@en
prefLabel
Mutant HRAS as novel target for MEK and mTOR inhibitors
@ast
Mutant HRAS as novel target for MEK and mTOR inhibitors
@en
Mutant HRAS as novel target for MEK and mTOR inhibitors.
@nl
P2093
P2860
P3181
P356
P1433
P1476
Mutant HRAS as novel target for MEK and mTOR inhibitors
@en
P2093
Alessandra Curioni-Fontecedro
Jesus Cosin-Roger
Kirstin Atrott
Michael K Kiessling
Michael Scharl
Panagiotis Samaras
Silvia Lang
P2860
P304
P3181
P356
10.18632/ONCOTARGET.5619
P407
P577
2015-12-08T00:00:00Z